Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

And those are AD, asthma, COPD, as you can see from the slide ... As seen in the pathway image on the right, IRF5 is a central node activated downstream of pattern recognition receptors that ...

Summer brings unique challenges for patients with COPD. Learn how rising temperatures and humidity affect symptoms and what ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD ... into the study were receiving background therapy, mainly with either long ...

Apogee Therapeutics, Inc. had promising results from its APG808 Phase 1b study show potential for every 2-month asthma ...

Verona filed for approval of ensifentrine last year on the strength of clinical data showing significant improvements in lung function with the drug in COPD patients, as well as a reduction in ...

Professor Chris Gale discusses a consensus statement on strategies for the identification and management of cardiopulmonary ...

Uncover the hidden risk of Legionella bacteria in your car's windshield wiper fluid and learn essential tips to ensure your ...

Adding one of these travel photos as your Zoom background takes way less time than getting through customs. Here's how it's done. Make sure you have Zoom virtual backgrounds enabled on your Zoom ...

(CNN) — Getting the shingles vaccine could do more than just prevent a painful red rash — it may also lower the risk of heart disease and stroke, according to a new South Korean study of more ...

Easily remove backgrounds from images with our Android background remover library. Optimized for bitmap processing, it delivers fast, accurate results for e-commerce, design apps, and more.